RICHMOND, Va., Nov. 14, 2001 (PRIMEZONE) -- Five Biotechnology companies will discuss prospects and strategies at this Saturday's Biotechnology Stocks Forum sponsored by Informed Investors. This virtual Forum, free to investors, is accessible over the Internet via www.informedinvestors.com from 8:30 a.m.-11 a.m. EST.
On Saturday, November 17, senior executives from five Biotechnology companies including Gene Logic Inc. (Nasdaq:GLGC), Hyseq, Inc. (Nasdaq:HYSQ) and Orchid BioSciences, Inc. (Nasdaq:ORCH) will speak for approximately 30 minutes each with PowerPoint presentations. Investors are invited to email questions to executives. The forum will also be archived on www.vcall.com and www.investorconference.com.
Other companies presenting at the forum include Integra Life Sciences and VaxGen. Adding to the depth of the Forum will be keynote speaker Dr. Staeckers, Assistant Professor in the Department of Surgery at University of Maryland.
Based in Gaithersburg, Maryland, Gene Logic, Inc. is a leading provider of biocontent and bioinformatics products related to gene activity in human disease and toxicity to optimize rapid, reliable and cost-effective pharmaceutical and biotechnology research and development. Through the systematic and industrialized application of genomics, the Company provides a growing portfolio of genomic information solutions based on its core database product, the GeneExpress(r) Suite.
Hyseq, Inc. of Sunnyvale, California is engaged in the research and development of biopharmaceutical products based upon its proprietary database of full-length human gene sequences. Hyseq's screening-by-hybridization platform provided a significant advantage in discovering novel, rarely expressed genes, and assembly of one of the most important proprietary databases of full-length human gene sequences.
Princeton, New Jersey-based, Orchid BioSciences recently announced that it has entered into an agreement with GlaxoSmithKline to collaborate on a genome-wide validation of single nucleotide polymorphisms (SNPs) for pharmacogenetic studies. As part of the collaboration, Orchid will develop SNP assays using well-established human DNA panels and will conduct ultra high throughput genotyping analyses.
Informed Investors is the leading producer of online and offline industry-specific investment conferences for individual investors and a member of the World Investor Link family of companies serving self-reliant individual investors.
About World Investor Link: Since 1992, World Investor Link (www.worldinvestorlink.com) has opened information channels from public companies to potential investors. This year World Investor Link will make more than 5 million investor introductions to over 4,600 corporate clients world wide through services including The Annual Reports Service, The Fund Info Service, Vcall (www.vcall.com), Investor Conference (www.investorconference.com) and Informed Investors Forums (www.informedinvestors.com). World Investor Links' array of products and services enables companies to comply with regulation fair-disclosure requirements by providing investors free access to onsite and Webcast investor events and company financial reports. Mutual funds and companies get visibility with investors at the point investors are making decisions through World Investor Link's relationships with over 160 of the leading financial media channels including The Wall Street Journal, Barron's and Yahoo!Finance. World Investor Link, Inc. a wholly owned subsidiary of WILink.com plc (WLK on The London Stock Exchange) began operations in Richmond, Va., in 1993.